Emcure Pharmaceuticals reported a major block deal as BC Investments IV Limited sold about 18 lakh shares worth Rs 289 crore to Norges Bank. The buyer’s entry comes as the pharma company keeps outperforming, posting a 67% return over the past 12 months and a 50% year-on-year jump in net profit, bolstering investor interest.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
